What is the Best Moment for Performing an HSG in Women With a Unfulfilled Childwish

PHASE4RecruitingINTERVENTIONAL
Enrollment

554

Participants

Timeline

Start Date

August 22, 2019

Primary Completion Date

December 1, 2025

Study Completion Date

January 1, 2026

Conditions
Female Infertility
Interventions
DRUG

Lipiodol UltraFluid

The investigational product is an oil-based contrast medium, Lipiodol® (Guerbet). Lipiodol® is a solution of ethyl esters of iodized fatty acids of poppy seed oil equivalent to 480mg I /ml and is a licensed contrast agent in the Netherlands (RVG 02806, see SmPC D2). The maximum amount of Lipiodol® per HSG procedure is 15 ml.

Trial Locations (1)

1081HV

RECRUITING

Amsterdam AMC, Amsterdam

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Amsterdam UMC, location VUmc

OTHER